mtrsl|i
dBMX|pi10884389|

pnInterf
ace|psa|
pda|p6Ad
ult|si|s

01|s111/08/2011|
s216:15|
s311/08/2011|s4
16:15|ci20111107
L410067|c01|ctbc
ilnk|cnBCI Downl
oad Exam|c3P|c4P
relimin
ary|ta|r
tast-p57
6|rnGram
 Positive Suscep
tibility
 - AST-P
576|rr2|
t2SU|t3S
uscepti

bility|t
4F|t5Fin
al|t11|o
1strpne|

o2Strept
ococcus 
pneumoni

ae|ra|a1
c|a2Chlo
ramphen

icol|a34
|a4S|ra|
a1e|a2Er

ythromyc
in|a3>=1
|a4R|ra|

a1imi|a2
Imipenem
|a30.5|a

4I|ra|a
1ofx|a2O
floxacin

|a32|a4S
|ra|a1pe
ng|a2Pen

icillin-
G|a3>=2|
a4R|ra|a

1pri|a2P
ristina
mycin|a3

<=2|a4S|
ra|a1rif
|a2Rifam

pin|a3<=
0.25|a4S
|ra|a1te

t|a2Tetr
acycline
|a3>=16

|a4R|ra|
a1sxt|a2
Trimetho

prim/Sul
fa|a380|
a4R|ra|a

1va|a2Va
ncomycin
|a3<=1|a

4S|ra|a1
lev|a2L
evofloxa
cin|a3<=


0.5|a4S|

ra|a1spx

|a2Sparf

loxacin|


a3<=0.12
|a4S|ra|

a1amx|a2


Amoxici

llin|a3>


=8|a4R|r

a|a1qda|


a2Quinup

ristin/D


alfopris


tin|a30.

5|a4S|ra


|a1ctr03


|a2Ceft

riaxone 


(non-men


ingitis)

|a3>=4|a

4R|ra|a1

lnz|a2Li

nezolid|


a3<=2|a4

S|ra|a1m


xf|a2Mo

xifloxac

in|a3<=0

.25|a4S|

ra|a1tax


03|a2Cef

otaxime 

(non-men

ingitis)


|a3>=4|a

4R|ra|a


1tel|a2T

elithrom
ycin|a3<


=0.25|a4

S|zz|78

